Cannara Biotech (OTCMKTS:CNBTF) Stock Price Up 0.9% – Still a Buy?

Cannara Biotech (OTCMKTS:CNBTF)’s stock price rose 0.9% on Thursday. The stock traded as high as $1.56 and last traded at $1.5140. Approximately 57,000 shares traded hands during mid-day trading, an increase of 72% from the average session volume of 33,127 shares. The stock had previously closed at $1.50.

Cannara Biotech Stock Performance

The business’s 50-day simple moving average is $1.41 and its 200-day simple moving average is $1.32.

Cannara Biotech Inc (OTCMKTS:CNBTF) is a Canadian cannabis company focused on the cultivation, processing and sale of indoor-grown cannabis and cannabis products. The company operates as a vertically integrated business, managing activities across cultivation, manufacturing, product development and distribution.

Cannara produces a range of cannabis offerings, including dried flower, pre-rolls, cannabis concentrates, hash, vaporizers and other cannabis-derived products. Its portfolio includes brands such as Tribal, Nugz and Orchid CBD, which are marketed through Canada’s regulated cannabis channels.

The company is based in Quebec and serves the Canadian cannabis market.